Literature DB >> 17937239

Infusion of intrathecal baclofen for acute withdrawal. Technical note.

Bradley S Duhon1, Joel D MacDonald.   

Abstract

Acute baclofen withdrawal syndrome is a life-threatening situation that demands early recognition and urgent treatment. The current therapy of choice for this syndrome is administration of intravenous benzodiazepines, propofol, and chemical paralytic drugs until the intrathecal system can be restored. The authors present a novel technique for administering baclofen intrathecally using a lumbar drain and a standard patient-controlled analgesia pump (in continuous infusion mode). In one case, this method was used to wean the patient from high-dose intrathecal baclofen treatment. In a second case, this method was used as a temporizing measure until the indwelling pump system could be repaired. In both cases, the patients recovered to their neurological baseline level, and lasting consequences of serious withdrawal were avoided.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17937239     DOI: 10.3171/JNS-07/10/0878

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  [Intrathecal baclofen therapy. Overdose during replacement of a medication pump].

Authors:  K Kramer; M Weber; A Koulousakis; H Lier; H Krep
Journal:  Anaesthesist       Date:  2009-09       Impact factor: 1.041

2.  Problem-Solving in Patients with Targeted Drug Delivery Systems.

Authors:  Rez Farid
Journal:  Mo Med       Date:  2017 Jan-Feb

3.  Dexmedetomidine for acute baclofen withdrawal.

Authors:  Simon Morr; Christopher M Heard; Veetai Li; Renée M Reynolds
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.